RNK-05047

N/A

Report date: 2025/03/05 20:00:52
NME

Base Information

Drug NameRNK-05047
Drug Alias NameRNK-05047BRD-4-CHAMP
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBromodomain-containing protein 4 degraders
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsSolid tumoursLymphoma, Large B-Cell, DiffuseLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesRanok Therapeutics (HK) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesRanok Therapeutics (Hangzhou) Co LtdRanok Therapeutics (HK) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, Large B-Cell, DiffuseLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A